ITOS
Iteos Therapeutics, Inc.
No insider bought or sold Iteos Therapeutics, Inc. in the last 12 months
ITOS over the last year
Prices for ITOS aren't in yet.
ITOS after insider buys
3 months after each buy, from the first price a copier could get.
3 buys since 2021 with 3 months of prices.
Every filing
86 insider filings since 2021, newest first
Ecor1 Capital, LLC · 10% owner
Matthew Gall · CFO
Boxer Capital, LLC · Insider
David Hallal · Director
Aaron I. Davis · Director
Aaron I. Davis · Director
Michel Detheux · CEO
Aaron I. Davis · Director
Michel Detheux · CEO
Boxer Capital, LLC · 10% owner
Joanne Jenkins Lager · Chief Medical Officer
Yvonne Mcgrath · Chief Scientific Officer
Michel Detheux · CEO
Joanne Jenkins Lager · Chief Medical Officer
Michel Detheux · CEO
Joanne Jenkins Lager · Chief Medical Officer
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Boxer Capital, LLC · Director and 10% owner
Joanne Jenkins Lager · Chief Medical Officer
Detlev Biniszkiewicz · Director
Matthew Gall · CFO
David Hallal · Director
Michel Detheux · CEO
Joanne Jenkins Lager · Chief Medical Officer
Joanne Jenkins Lager · Chief Medical Officer
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Mpm Bioventures 2014, L.P. · 10% owner
Michel Detheux · CEO
Ansbert Gadicke · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Joanne Jenkins Lager · Chief Medical Officer
Michel Detheux · CEO
Michel Detheux · CEO
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Mpm Bioventures 2014, L.P. · 10% owner
Mpm Bioventures 2018, L.P. · 10% owner
Ansbert Gadicke · 10% owner
Mpm Bioventures 2014, L.P. · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.